Arno Therapeutics, Inc Interest Expense on Debt
Arno Therapeutics, Inc reported Interest Expense on Debt of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2015-03-31
- Arno Therapeutics, Inc interest expense, debt for the quarter ending 2013-12-31 was $13.47M.
- Arno Therapeutics, Inc interest expense, debt for the quarter ending 2013-09-30 was $0.00.
- Arno Therapeutics, Inc interest expense, debt for the quarter ending 2013-06-30 was $0.00.
- Arno Therapeutics, Inc interest expense, debt for the quarter ending 2013-03-31 was $5.10M.
- Arno Therapeutics, Inc interest expense, debt for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- Arno Therapeutics, Inc interest expense, debt for fiscal 2013 was $18.57M.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month | Interest Expense, Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-31 | ||||
| 2013-12-31 | $13.47M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $13.47M derived: sum of 2 quarters · filed 2015-03-31 | $13.47M derived: sum of 3 quarters · filed 2015-03-31 | $18.57M 10-K · filed 2015-03-31 | $5.10M 10-K · filed 2014-03-31 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $5.10M 10-Q · filed 2013-11-14 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $5.10M 10-Q · filed 2013-08-14 | |||
| 2013-03-31 | $5.10M 10-Q · filed 2013-05-15 |